Download 0 ADD

ADDENDUM
AZ ÖSSZEÁLLÍTÁS BEFEJEZÉSE UTÁN,
2011-BEN MEGJELENT FONTOSABB KÖZLEMÉNYEK
az NK sejtekkel kapcsolatosan – full-text
(Klinikai és „elméleti” vonatkozások; lezárva: 2011 szeptember)
01 Bleakley M, Riddell SR:
Exploiting T cells specific for human minor histocompatibility antigens for therapy of
leukemia.
Immunol Cell Biol. 2011 Mar; 89(3): 396-407.
02. Johnston MF, Ortiz Sánchez E, Vulanovic NL, Li W:
Acupuncture may stimulate anticancer immunity via activation of natural killer cells.
Evid Based Complement Alternet Med. 2011; 2011: 481625.
03. Bryceson YT, Ljunggren HG:
Natural killer cells: biology, physiology and medicine − part 1.
J Innate Immun. 2011; 3(3): 213-5.
04. Bryceson YT, Chang SC, Darmanin S el al:
Molecular mechanisms of natural killer cell activation.
J Innate Immun. 2011; 3(3): 216-26.
05. Romagné F, Vivier E:
Natural killer cell-based therapies.
F1000 Med Rep. 2011; 3: 9.
06. Joyce MG, Sun PD:
The structural basis of ligand recognition by natural killer cell receptors.
J Biomed Biotechnol. 2011; 2011: 203628.
07. Alderson KL, Sondel PM:
Clinical cancer therapy by NK cells via antibody-dependent cell-mediated cytotoxicity.
J Biomed Biotechnol. 2011; 2011: 379123.
08. Bryceson YT, Ljunggren HG:
Natural killer cells: biology, physiology and medicine − part 2.
J Innate Immun. 2011; 3(4): 327-8.
09. Meazza R, Azzarone B, Orengo AM, Ferrini S:
Role of common-gamma chain cytokines in NK cell development and function:
perspectives for immunotherapy.
J Biomed Biotechnol. 2011; 2011: 861920.
10. Sangiolo D:
Cytokine induced killer cells as promising immunotherapy for solid tumors.
J Cancer, 2011; 2: 363-8.
11. Thomas JA, Badini M:
The role of innate immunity in spontaneous regression of cancer.
Indian J Cancer. 2011 Apr-Jun; 48(2): 246-51.
12. Jewett A, Tseng HC:
Tumor induced inactivation of natural killer cell cytotoxic function:
implication in growth, expansion and differentiation of cancer stem cells.
J Cancer. 2011, 2. 443-57.
13. Biassoni R, Coligan JE, Moretta L:
Natural killer cells in healthy and diseased subjects.
J Biomed Biotechnol. 2011; 2011: 795251.
14. Hayley M, Bourbigot S, Booth V:
Self-association of an activating natural killer cell receptor, KIR2DS1.
PLoS One. 2011; 6(8): e23052.
15. Sugita K, Kabashima K, Tokura Y:
Characterization of peripheral natural killer cells and their reduction
in drug-induced hypersensitivity syndrome.
Acta Derm Venereol. 2011 Aug 31. [Epub ahead of print]
16. Eidson M, Wahlstrom J, Beaulieu AM et al.:
Altered development of NKT cells, γδ T cells, CD8 T cells and NK cells
in a PLZF deficient patient.
PLoS One. 2011; 6(9): e24441.
17 Rak GD, Mace EM, Banerjee PP et al.:
Natural killer cell lytic granule secretion occurs through a pervasive actin network
at the immune synapse.
PLoS Biol. 2011 Sep; 9(9): e1001151
18. Brown AC, Oddos S, Dobbie IM et al.:
Remodelling of cortical actin where lytic granule dock at natural killer cell
immune synapses revealed by super-resolution microscopy.
PLoS Biol. 2011 Sep; 9(9): e1001152.
19. Lo Monaco E, Tremante E, Cerboni C et al.:
Human leukocyte antigen e contributes to protect tumor cells from lysis
by natural killercells.
Neoplasia. 2011 Sep; 13(9): 822-30.